Serum Institute of India (SII) issued an August 23 in which it stated that all claims related to the availability of its COVID-19 vaccine, COVISHIELD, in 73 days are false.
“Currently, the government has granted us permission to manufacture only the vaccine and buy it for long-term use,” SII said in a Facebook post, adding that COVISHIELD will not be announced until after successful testing and after all required regulations. are in place.
Phase 3 trials are ongoing. We will officially check your availability.
Covid-19 vaccine
Faq
Read the explanation here – https://t. co/FvgClzcnHr#SII – COVID19 #LatestNews pic. twitter. com/mQWrqgbzO4
The SII also talked about the Oxford-AstraZeneca vaccine. ” Phase 3 trials for the Oxford-AstraZeneca vaccine are still ongoing. And once the vaccine is immunogenic and effective, the SII will officially verify its availability,” the company said.
Coronavirus Essential India becomes the most affected country at the moment; Russian vaccine trials will be retested in India, according to a report